Dioleoyl phosphatidylglycerol

CAS Number: 62700-69-0

Molecular Formula: C42H79O10P

About Dioleoyl phosphatidylglycerol

Dioleoyl phosphatidylglycerol CAS 62700-69-0 serves as a premier negatively charged phospholipid essential for the API intermediates market, particularly in the development of advanced liposomal drug delivery systems and nanoemulsions to enhance the bioavailability of hydrophobic therapeutic agents. 1,2-Dioleoyl-sn-gly...

Dioleoyl phosphatidylglycerol Specifications

CAS Number

62700-69-0

Molecular Formula

C42H79O10P

Molecular Weight

797.03 g/mol

IUPAC Name

[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-octadec-9-enoate

Canonical SMILES

CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)OC(=O)CCCCCCC/C=C\CCCCCCCC

InChI Key

DSNRWDQKZIEDDB-CLFAGFIQSA-N

CAS Number

62700-69-0

Molecular Formula

C42H79O10P

Molecular Weight

797.03 g/mol

IUPAC Name

[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-octadec-9-enoate

Canonical SMILES

CCCCCCCC/C=C\CCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)OC(=O)CCCCCCC/C=C\CCCCCCCC

InChI Key

DSNRWDQKZIEDDB-CLFAGFIQSA-N

Molecular Weight

797.03 g/mol

Biochemical Assay Reagent

A negatively charged phosphatidylglycerol phospholipid used in biochemical assay research to inhibit the production of inflammatory mediators in macrophages and study the activation of Toll-like receptors

Drug Delivery System

A functional lipid component utilized in the construction of drug delivery carriers, including micelles, liposomes, and other artificial membranes for the improved bioavailability and controlled release of pharmaceuticals

Membrane Biology Research

A synthetic phospholipid applicable to studies of membrane biology, drug-membrane interactions, and the stabilization of lipid monolayers to mimic biological systems like lung surfactants or mitochondrial membranes

Pharmaceutical Intermediate

A high-purity precursor and building block used in the synthesis of active pharmaceutical ingredients and the development of treatments for chronic sterile corneal inflammation and diabetic wound healing.